1839-18-5 | 2-Chloroadenine

Packsize	Purity	Availability	Price	Discounted Price
1g	97%	in stock	$7.00	$5.00
5g	97%	in stock	$15.00	$11.00
10g	97%	in stock	$29.00	$20.00
25g	95%	in stock	$67.00	$47.00
100g	95%	in stock	$268.00	$188.00

Description

• Catalog Number: AB43981
• Chemical Name: 2-Chloroadenine
• CAS Number: 1839-18-5
• Molecular Formula: C5H4ClN5
• Molecular Weight: 169.5718
• MDL Number: MFCD00037925
• SMILES: Clc1nc(N)c2c(n1)nc[nH]2
• NSC Number: 7362

Computed Properties

• Complexity: 154
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 11
• Hydrogen Bond Acceptor Count: 4
• Hydrogen Bond Donor Count: 2
• XLogP3: 0.4

Literature

• Correlation of the time course of development and decay of tolerance to morphine with alterations in sodium pump protein isoform abundance.

  Biochemical pharmacology 20100401

• Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: possible involvement of adenosinergic mechanism.

  Epilepsy research 20080101

• [Synthesis of 2-chloro-2'-deoxyadenosine by microbiological transglycosylation using a recombinant Escherichia coli strain].

  Prikladnaia biokhimiia i mikrobiologiia 20080101

• New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile.

  Purinergic signalling 20070901

• Age-related changes in ischemic tolerance in male and female mouse hearts.

  Journal of molecular and cellular cardiology 20050201

• Application of population pharmacokinetics to cladribine.

  BMC pharmacology 20050101

• Kinetic model of oxidation catalyzed by xanthine oxidase-the final enzyme in degradation of purine nucleosides and nucleotides.

  Nucleosides, nucleotides & nucleic acids 20050101

• Human DNA primase uses Watson-Crick hydrogen bonds to distinguish between correct and incorrect nucleoside triphosphates.

  Biochemistry 20040928

• Cytotoxicity and pharmacokinetics of cladribine metabolite, 2-chloroadenine in patients with leukemia.

  Cancer letters 20040716

• Determination of the deoxycytidine kinase activity in cell homogenates with a non-radiochemical assay using reversed-phase high performance liquid chromatography; Identification of a novel metabolite of 2-chlorodeoxyadenosine.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040615

• Synthesis of base substituted 2-hydroxy-3-(purin-9-yl)-propanoic acids and 4-(purin-9-yl)-3-butenoic acids.

  Nucleosides, nucleotides & nucleic acids 20031201

• Oligonucleotides incorporating 8-aza-7-deazapurines: synthesis and base pairing of nucleosides with nitrogen-8 as a glycosylation position.

  Organic & biomolecular chemistry 20030607

• 3'-deoxyribofuranose derivatives of 1-deaza and 3-deaza-adenosine and their activity as adenosine deaminase inhibitors.

  Nucleosides, nucleotides & nucleic acids 20010101

• Structure-activity relationships for the binding of ligands to xanthine or guanine phosphoribosyl-transferase from Toxoplasma gondii.

  Biochemical pharmacology 19951109